{"id":"https://openalex.org/W2808736865","doi":"https://doi.org/10.2337/db18-519-p","title":"Circulating MicroRNAs Associated with Incident End-Stage Renal Disease in Chinese with Type 2 Diabetes","display_name":"Circulating MicroRNAs Associated with Incident End-Stage Renal Disease in Chinese with Type 2 Diabetes","publication_year":2018,"publication_date":"2018-06-22","ids":{"openalex":"https://openalex.org/W2808736865","doi":"https://doi.org/10.2337/db18-519-p","mag":"2808736865"},"language":"en","primary_location":{"id":"doi:10.2337/db18-519-p","doi":"https://doi.org/10.2337/db18-519-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-519-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007921065","display_name":"Baoqi Fan","orcid":"https://orcid.org/0000-0001-6728-419X","observed_orcids":["https://orcid.org/0000-0001-6728-419X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"BAOQI FAN","raw_affiliation_strings":["Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hong Kong, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021394512","display_name":"Heung Man Lee","orcid":"https://orcid.org/0000-0002-5199-1778","observed_orcids":["https://orcid.org/0000-0002-5199-1778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HEUNG MAN LEE","raw_affiliation_strings":["Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hong Kong, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028269324","display_name":"Cadmon K.P. Lim","orcid":"https://orcid.org/0000-0001-5523-9199","observed_orcids":["https://orcid.org/0000-0001-5523-9199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CADMON K.P. LIM","raw_affiliation_strings":["Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hong Kong, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"RICHARD CHOY","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RICHARD CHOY","raw_affiliation_strings":["Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hong Kong, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091832416","display_name":"Juliana C.N. Chan","orcid":"https://orcid.org/0000-0003-1325-1194","observed_orcids":["https://orcid.org/0000-0003-1325-1194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JULIANA C. CHAN","raw_affiliation_strings":["Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hong Kong, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040544030","display_name":"Andrea O. Y. Luk","orcid":"https://orcid.org/0000-0002-5244-6069","observed_orcids":["https://orcid.org/0000-0002-5244-6069"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ANDREA LUK","raw_affiliation_strings":["Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hong Kong, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100447655","display_name":"Ronald C.W.","orcid":"https://orcid.org/0000-0002-1227-803X","observed_orcids":["https://orcid.org/0000-0002-1227-803X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RONALD C. MA","raw_affiliation_strings":["Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hong Kong, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.07689657,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"67","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.8270999789237976,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.8270999789237976,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.16500000655651093,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/circulating-micrornas","display_name":"circulating microRNAs","score":0.871999979019165},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.968999981880188},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.8820000290870667},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7820000052452087},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.6389999985694885},{"id":"https://openalex.org/keywords/adrenergic-signaling","display_name":"adrenergic signaling","score":0.8220000267028809},{"id":"https://openalex.org/keywords/peroxisomes","display_name":"peroxisomes","score":0.8709999918937683},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.7739999890327454},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.5839999914169312},{"id":"https://openalex.org/keywords/dialysis","display_name":"dialysis","score":0.44600000977516174},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.8230000138282776},{"id":"https://openalex.org/keywords/risk-prediction-model","display_name":"risk prediction model","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7318451404571533},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.7006160020828247},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5658739805221558},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5618137717247009},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.5471592545509338},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5452138185501099},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.512696385383606},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4779011011123657},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4560631513595581},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4385329782962799},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.43455269932746887},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.43364205956459045},{"id":"https://openalex.org/C2779018089","wikidata":"https://www.wikidata.org/wiki/Q17014303","display_name":"Fold change","level":4,"score":0.4175335466861725},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3977268636226654},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.33683639764785767},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2982747554779053},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18457135558128357},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.10211321711540222},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05792003870010376},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db18-519-p","doi":"https://doi.org/10.2337/db18-519-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-519-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415474546","https://openalex.org/W4413476664","https://openalex.org/W4206474158","https://openalex.org/W2918854174","https://openalex.org/W4380625760","https://openalex.org/W3159413098","https://openalex.org/W4396997241","https://openalex.org/W3031864346","https://openalex.org/W6992983019","https://openalex.org/W3168321930"],"abstract_inverted_index":{"Objectives:":[0],"We":[1,22],"aimed":[2],"to":[3,133,175,198,239,283],"identify":[4],"novel":[5],"serum":[6,92,260],"micro(mi)RNAs":[7],"associated":[8,230,268],"with":[9,17,30,162,171,231,269],"incident":[10,172,273],"end-stage":[11],"renal":[12,57,78,178],"disease":[13,222,289],"(ESRD)":[14],"in":[15,28,35,137,169,191,209],"Chinese":[16],"type":[18,31],"2":[19,32],"diabetes.":[20],"Methods:":[21],"conducted":[23],"a":[24,148],"nested":[25],"case-control":[26],"study":[27],"patients":[29,47,74,170],"diabetes":[33],"enrolled":[34],"the":[36,154,186,210,278],"Hong":[37],"Kong":[38],"Diabetes":[39,346],"Registry":[40],"between":[41],"1995":[42],"and":[43,83,101,104,118,122,140,158,167,204,221,227,233,256,264,324,369],"2007.":[44],"Cases":[45],"were":[46,49,73,88,106,124,131,160,206,229],"who":[48,75],"free":[50],"from":[51,90],"ESRD":[52,116,173],"at":[53,80,94],"enrolment":[54],"but":[55],"developed":[56],"endpoint":[58],"as":[59,61,285],"defined":[60],"eGFR":[62],"<":[63],"15":[64],"ml/min/1.73m2":[65],"or":[66,196],"dialysis":[67],"during":[68,84],"follow-up":[69],"until":[70],"2015.":[71],"Controls":[72],"had":[76],"normal":[77],"function":[79],"both":[81],"baseline":[82,254],"observation":[85],"period.":[86],"MicroRNAs":[87],"extracted":[89],"stored":[91],"collected":[93],"baseline.":[95],"Discovery":[96],"cohort":[97,113],"included":[98,114],"22":[99],"cases":[100,117],"21":[102],"controls":[103,121],"miRNAs":[105,123,130,188,282],"screened":[107],"by":[108,147],"Agilent":[109],"microRNA":[110],"microarray.":[111],"Validation":[112],"361":[115],"241":[119],"T2D":[120],"quantitated":[125],"using":[126],"qRT-PCR.":[127],"Two":[128],"spike-in":[129],"used":[132],"control":[134],"for":[135,218,246,251,288],"efficiency":[136],"RNA":[138,150],"extraction":[139],"reverse":[141],"transcription.":[142],"Batch":[143],"difference":[144],"was":[145],"adjusted":[146,217,250],"positive":[149],"control.":[151],"Results:":[152],"In":[153],"discovery":[155],"analysis,":[156],"miR-X":[157,203,226,263],"miR-Y":[159,205,228,247,265],"elevated":[161],"respective":[163],"fold-change":[164],"of":[165,202,225,237,262,272,280],"5.97":[166],"4.43":[168],"compared":[174],"those":[176],"without":[177],"events":[179],"on":[180],"follow-up.":[181],"Pathway":[182],"analysis":[183],"revealed":[184],"that":[185],"two":[187],"may":[189],"involve":[190],"signaling":[192],"transduction,":[193],"adrenergic":[194],"signaling,":[195],"relate":[197],"peroxisome.":[199],"Increased":[200],"levels":[201,261],"also":[207],"detected":[208],"validation":[211],"cohort.":[212],"Using":[213],"binary":[214],"logistic":[215],"regression":[216],"age,":[219],"sex":[220],"duration,":[223],"doubling":[224],"14.2%":[232],"26.3%":[234],"higher":[235,270],"odds":[236],"progressing":[238],"ESRD,":[240],"respectively.":[241],"The":[242],"association":[243],"remained":[244],"significant":[245],"when":[248],"further":[249],"metabolic":[252],"indices,":[253],"albuminuria":[255],"eGFR.":[257],"Conclusions:":[258],"Baseline":[259],"are":[266],"independently":[267],"risk":[271],"ESRD.":[274],"These":[275],"results":[276],"indicate":[277],"potential":[279],"circulating":[281],"serve":[284],"prognostic":[286],"indicators":[287],"progression.":[290],"Disclosure":[291],"B.":[292],"Fan:":[293],"None.":[294,297,300,303],"H.":[295],"Lee:":[296],"C.K.P.":[298],"Lim:":[299],"R.":[301],"Choy:":[302],"J.C.":[304],"Chan:":[305],"Consultant;":[306,315,328,359],"Self;":[307,312,316,320,329,339,344,349,353,360,375,383,389,402],"Bayer":[308,313,391],"AG.":[309,314],"Other":[310,318,337,351],"Relationship;":[311,319,338,352],"Sanofi.":[317,384],"Sanofi,":[321],"Eli":[322,367],"Lilly":[323,368],"Company,":[325],"Amgen":[326],"Inc..":[327,336,341,380,399],"AstraZeneca,":[330,376,390],"Merck":[331,354,393],"&":[332,356,395],"Co.,":[333],"Inc.,":[334,364],"Pfizer":[335,340,398],"Board":[342],"Member;":[343],"Asia":[345],"Foundation.":[347],"Stock/Shareholder;":[348],"GemVCare.":[350],"Sharp":[355,394],"Dohme":[357,396],"Corp..":[358],"Boehringer":[361,377,403,407],"Ingelheim":[362,378,404,408],"Pharmaceuticals,":[363,379],"Novartis":[365],"AG,":[366,392],"Company.":[370],"A.":[371],"Luk:":[372],"Advisory":[373,400],"Panel;":[374,401],"Research":[381,387],"Support;":[382,388],"R.C.":[385],"Ma:":[386],"Corp.,":[397],"GmbH,":[405],"Nippon":[406],"Co.":[409],"Ltd..":[410]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2018-06-29T00:00:00"}